Cell-free fetal DNA and maternal serum analytes for monitoring embryonic and fetal status

Fertility and Sterility

Volumn 99, Issue 4, 2013, Pages 1124-1134

  Simpson, Joe Leigh ^a  

^a March of Dimes Birth Defects Foundation   (United States)

Author keywords

cell free DNA; fetal aneuploidy; noninvasive; Prenatal diagnosis

Indexed keywords

CELL FREE FETAL DNA; DNA; UNCLASSIFIED DRUG;

ANEUPLOIDY; AUTOSOMAL DISORDER; CHORION VILLUS SAMPLING; CHROMOSOME DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; CYSTIC FIBROSIS; DNA SEQUENCE; FALSE POSITIVE RESULT; FETUS CELL; FIRST TRIMESTER PREGNANCY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC SCREENING; GENOTYPE; HUMAN; MATERNAL BLOOD; MATERNAL SERUM; MATERNAL SERUM SCREENING TEST; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL MUSCULAR ATROPHY; TRISOMY 18; TRISOMY 21; TROPHOBLAST; ULTRASOUND;

BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, PAIR 18; DNA; DOWN SYNDROME; FEMALE; GENETIC TESTING; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; TRISOMY;

EID: 84876401747     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.02.012     Document Type: Conference Paper

References (67)

1. J.L. Simpson, W. Holzgreve, and D.A. Driscoll Genetic counseling and genetic screening S.A. Gabbe, J.F. Niebyl, J.L. Simpson, M.B. Landon, H.L. Galan, E.R.M. Jauniaux, D.A. Driscoll, Obstetrics: normal and problem pregnancies 6th ed. 2012 Elsevier Philadelphia, PA 193 209
2. J.L. Simpson, D.S. Richards, L. Otaño, and D.A. Driscoll Prenatal genetic diagnosis S.A. Gabbe, J.R. Niebyl, J.L. Simpson, M.B. Landon, H.L. Galan, E.R.M. Jauniaux, D.A. Driscoll, Obstetrics: normal and problem pregnancies 6th ed. 2012 Elsevier Philadelphia, PA 210 236
3. J.L. Simpson Invasive procedures for prenatal diagnosis. Any future left? Best Pract Res Clin Obstet Gynaecol 26 2012 625 638
4. R. Wapner, E. Thom, J.L. Simpson, E. Pergament, R. Silver, and K. Filkins First trimester screening for trisomies 21 and 18 N Engl J Med 349 2003 1405 1413
5. N.J. Wald, C. Rodeck, A.K. Hackshaw, J. Walters, L. Chitty, and A.M. Mackinson First and second trimester antenatal screening for Down's syndrome: the results of the serum, urine and ultrasound screening study (SURUSS) J Med Screen 10 2003 56 104
6. F.D. Malone, J.A. Canick, R.H. Ball, D.A. Nyberg, C.H. Comstock, and R. Bukowski First-trimester or second trimester screening or both for Down's syndrome N Engl J Med 353 2005 2001 2011
7. C.H. Comstock, F.D. Malone, R.H. Ball, D.A. Nyberg, G.R. Saade, and R.L. Berkowitz Is there nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol 195 2006 843 847
8. R. Bindra, V. Heath, A. Liao, K. Spencer, and K.H. Nicolaides One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies Ultrasound Obstet Gynecol 20 2002 219 225
9. K. Avgidou, A. Papageorghiou, R. Bindra, K. Spencer, and K.H. Nicolaides Prospective first-trimester screening for trisomy 21 in 30, 564 pregnancies Am J Obstet Gynecol 192 2005 1761 1767
10. G.E. Palomaki, G.J. Knight, J.E. Haddow, J.A. Canick, D.N. Saller Jr., and D.S. Panizza Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin Prenat Diagn 12 1992 925 930
11. G.E. Palomaki, G.J. Knight, J.E. Haddow, N.J. Wald, A. Kennard, and J.A. Canick Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin Prenat Diagn 15 1995 713 723
12. F.D. Malone, H. Cuckle, and R.H. Ball Contingent screening for trisomy 21 results from a general population screening trial Am J Obstet Gynecol 193 2005 S29
13. G.P. Henry, D.W. Britt, and M.I. Evans Screening advances and diagnostic choice: The problem of residual risk Fetal Diagn Ther 23 2008 308 315
14. American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities Obstet Gynecol 109 2007 217 227
15. R.J. Wapner, L.M. Christa, B. Levy, B.C. Ballif, C.M. Eng, and J.M. Zachary Chromosomal microarray compared with karyotyping for prenatal diagnosis N Engl J Med 367 2012 2175 2184
16. American College of Obstetricians and Gynecologists ACOG Committee Opinion 545: noninvasive prenatal testing for fetal aneuploidy Obstet Gynecol 120 2012 1532 1534
17. X.Q. Chen, M. Stroun, J.-L. Magnetat, L.P. Nicod, A.M. Kurt, and J. Lyautey Microsatellite alterations in plasma DNA of small cell lung cancer patients Nat Med 1996 1033 1035
18. Y.M. Lo, N. Crobetta, P.F. Chamberlain, V. Rai, I.L. Sargent, and C.W. Redman Presence of fetal DNA in maternal plasma serum Lancet 350 1997 485 487
19. S.A. Devaney, G.E. Palomaki, J.A. Scott, and D.W. Bianchi Noninvasive fetal sex differentiation using cell free fetal DNA JAMA 306 2011 627 636
20. C. Lewis, M. Hill, H. Skirton, and L.S. Chitty Fetal sex determination using cell-free fetal DNA: service users' experiences of and preferences for service delivery Prenat Diagn 32 2012 735 741
21. N.B. Tsui, R.A. Kadir, K.C. Chan, C. Chi, G. Mellars, and E.G. Tuddenham Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA Blood 117 2011 3684 3691
22. R.W. Chiu, T.K. Lau, P.T. Cheung, Z.Q. Gong, T.N. Leung, and Y.M. Lo Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study Clin Chem 48 2002 778 780
23. F.B. Clausen, M. Christiansen, R. Steffenson, S. Jørgensen, C. Nielsen, and M.A. Jakobsen Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis Transfusion 52 2012 752 758
24. M.E. Norton, H. Brar, J. Weiss, A. Karimi, L.C. Laurent, and A.B. Caughey Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18 Am J Obstet Gynecol 207 2012 137.e1 137.e8
25. K.H. Nicolaides, A. Syngelaki, G. Ashoor, C. Birdir, and G. Touzet Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population Am J Obstet Gynecol 207 2012 374.e1 374.e6
26. Y.M.D. Lo, T.K. Lau, J. Zhang, T.N. Leung, A.M. Chang, and N.M. Hjelm Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21 Clin Chem 45 1999 1747 1751
27. G.E. Palomaki, E.M. Kloza, G.M. Lambert-Messerlian, J.E. Haddow, L.M. Neveux, and M. Ehrich DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study Genet Med 13 2011 913 920
28. M. Ehrich, C. Deciu, T. Zwiefelhofer, J.A. Tynan, L. Cagasan, and R. Tim Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting Am J Obstet Gynecol 204 2011 205.e1 205.e11
29. R.W. Chiu, R. Akolekar, Y.W.L. Zheng, T.Y. Leung, H. Sun, and K.C. Chan Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large-scale validity study BMJ 342 2011 c7401
30. E.Z. Chen, R.W. Chiu, H. Sun, R. Akolekar, K.C. Chan, and T.Y. Leung Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing PLoS One 6 2011 e21791
31. H.C. Fan, Y.J. Blumenfeld, U. Chitkara, L. Hudgins, and S.R. Quake Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood Proc Natl Acad Sci USA 105 2008 16266 16271
32. A.J. Sehnert, B. Rhees, D. Comstock, E. de Feo, G. Heilek, J. Burke, and R.P. Rava Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood Clin Chem 57 2011 1042 1049
33. D.W. Bianchi, L.K. Platt, J.D. Goldberg, A.Z. Abuhamad, A.J. Sehnert, and R.P. Rava MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing Obstet Gynecol 119 2012 1 12
34. S. Dan, W. Wang, J. Ren, Y. Li, H. Hu, and Z. Xu Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors Prenat Diagn 32 2012 1225 1232
35. A.B. Sparks, E.T. Wang, C.A. Struble, W. Barrett, R. Stokowski, and C. McBride Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy Prenat Diagn 32 2012 3 9
36. A.B. Sparks, C.A. Struble, E.T. Wang, K. Song, and A. Oliphant Non-invasive prenatal detection and selective analysis of cell-fee DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18 Am J Obstet Gynecol 206 2012 319.e1 319.e9
37. G. Ashoor, A. Syngelaki, M. Wagner, C. Birdir, and K.H. Nicholiades Chromosome-selective sequencing of maternal plasma cell-fee DNA for first-trimester detection of trisomy 21 and trisomy 18 Am J Obstet Gynecol 206 2012 322.e1 322.e5
38. Z. Demko, B. Zimmermann, and M. Rabinowitz Non-invasive prenatal testing for whole chromosome abnormalities J Lab Med 36 2012 263 267
39. D.S. Johnson, G. Gemelos, J. Baner, A. Ryan, C. Cinnioglu, and M. Banjevic Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol Hum Reprod 25 2010 1066 1075
40. B. Zimmermann, M. Hill, and G. Gemelos Noninvasive prenatal aneuploidy testing at chromosomes 13, 18, 21, X and Y, using targeted sequencing of polymorphic loci Prenat Diagn 32 2012 1233 1241
41. J.L. Simpson Is cell-free fetal DNA from maternal blood finally ready for prime time? Obstet Gynecol 119 2012 883 885
42. J.L. Simpson Noninvasive fetal diagnosis: Promise versus practicality Contemporary Ob Gyn 58 2013 26 33
43. P. Benn, A. Borrell, H. Cuckle, L. Dugoff, S. Gross, and J.A. Johnson Prenatal detection of Down Syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 Prenat Diagn 32 2012 1 2
44. J.O. Price, S. Elias, S.S. Wachtel, K. Klinger, M. Dockter, and A. Tharapel Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry Am J Obstet Gynecol 165 1991 1731 1737
45. S. Elias, J. Price, M. Dockter, S. Wachtel, A. Tharapel, J.L. Simpson, and K.W. Klinger First trimester prenatal diagnosis of trisomy 21 in fetal cells from maternal blood Lancet 340 1992 1033
46. J.L. Simpson, and S. Elias Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology JAMA 270 1993 2357 2361
47. D.W. Bianchi, A. Mahr, G.K. Zickwolf, T.W. Houseal, A.F. Flint, and K.W. Klinger Detection of fetal cells with 47, XY, +21 karyotype in maternal peripheral blood Hum Genet 19 1992 368 370
48. A.D. Ganshirt, S.R. Borjesson, M. Burschyk, A. Dohr, H.S. Garritsen, and E. Helmer Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting Am J Reprod Immunol 30 1993 194 201
49. D.W. Bianchi, J.L. Simpson, L.G. Jackson, S. Elias, W. Holzgreve, and M.I. Evans Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study Prenat Diagn 22 2002 609 615
50. F.Z. Bischoff, and J.L. Simpson Endocervical fetal trophoblast for prenatal genetic diagnosis Curr Opin Obstet Gynecol 18 2006 216 220
51. H. Mouawia, A. Saker, J.P. Jais, A. Benachi, L. Bussières, and B. Lacour Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy Reprod Biomed Online 25 2012 508 520
52. G. Vona, C. Béroud, A. Benachi, A. Quenette, J.P. Bonnefont, and S. Romana Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood Am J Pathol 160 2002 51 58
53. C. Beroud, M. Karliova, J.P. Bonnefont, A. Benachi, A. Munnich, and Y. Dumez Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells Lancet 361 2003 1013 1014
54. A. Saker, A. Benachi, and J.P. Bonnefont Genetic characterization of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis Prenat Diagn 26 2006 906 916
55. J.L. Simpson Preimplantation genetic diagnosis at 20 years Prenat Diagn 30 2010 682 695
56. A. Kuliev Practical preimplantation genetic diagnosis 2nd ed. 2012 Springer-Verlag London
57. K.W. Lam, P. Jiang, G.J. Liao, K.C. Chan, T.Y. Leung, and R.W. Chiu Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia Clin Chem 58 2012 1467 1475
58. J.O. Kitzman, M.W. Snyder, M. Ventura, A.P. Lewis, R. Qiu, and L.E. Simmons Noninvasive whole-genome sequencing of a human fetus Sci Transl Med 4 2012 137ra76
59. D.W. Bianchi From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges Nat Med 18 2012 1041 1051
60. L.L. Poon, T.N. Leung, T.K. Lau, and Y.M. Lo Presence of fetal RNA in maternal plasma Clin Chem 46 2000 1832 1834
61. N.B. Tsiu, E.K. Ng, and Y.M. Lo Stability of endogenous and added RNA in blood specimens, serum, and plasma Clin Chem 48 2002 1647 1653
62. J.L. Maron, K.L. Johnson, D. Slonim, C.Q. Lai, M. Ramoni, and G. Alterovitz Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood J. Clin Invest 117 2007 3007 3019
63. S.S. Luo, O. Ishibashi, G. Ishikawa, T. Ishikawa, A. Katayama, and T. Mishima Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes Biol Reprod 81 2009 717 729
64. N.J. Wald, J.P. Bestwick, L.M. George, T. Wu, and J.K. Morris Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome quadruple test markers J Med Screen 19 2012 60 67
65. E.K. Ng, T.N. Leung, N.B. Tsui, T.K. Lau, N.S. Panesar, and R.W. Chiu The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia Clin Chem 49 2003 727 731
66. M. Løset, S.B. Mundal, M.P. Johnson, M.H. Fenstad, K.A. Freed, and I.A. Lian A transcriptional profile of the decidua in preeclampsia Am J Obst Gynecol 204 2011 E1 27
67. M. Ishida, D. Monk, A.J. Duncan, S. Abu-Amero, J. Chong, and S.M. Ring Maternal inheritance of a promoter variant in the imprinted PHLDA2 gene significantly increases birth weight Am J Hum Genet 90 2012 715 719